IMR Press / CEOG / Volume 42 / Issue 3 / DOI: 10.12891/ceog1823.2015

Clinical and Experimental Obstetrics & Gynecology (CEOG) is published by IMR Press from Volume 47 Issue 1 (2020). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.

Original Research
Female genital mutilation/cutting: an update
Show Less
1 Department of Obstetrics and Gynecology, King Abdulaziz University, Jeddah (Saudi Arabia)
2 Department of Obstetrics and Gynecology, McGill University, Montreal (Canada)
Clin. Exp. Obstet. Gynecol. 2015, 42(3), 300–303; https://doi.org/10.12891/ceog1823.2015
Published: 10 June 2015
Abstract

Female genital mutilation/cutting (FGM/C) is a cultural practice involving several types of external female genitalia cutting. FGM/C is known to occur in all parts of the world but is most prevalent in 28 countries in Africa and the Middle East and among immigrant communities in Europe, Australia, New Zealand, Canada, and the United States. Studies of FGM/C suffer from many methodological problems including inadequate analysis and an unclear reporting of results. The evidence to link FGM/C to infertility is weak. The management of epidermal clitoral inclusion cysts includes expensive investigations like comprehensive endocrinology tests and MRI resulting in unnecessary anxiety due to delay in surgical treatment. Similarly, unnecessary cesarean sections or rupture of the infibulation scar continue to occur because of the inadequate use of intrapartum defibulation. A significant amount of efforts is required to improve and correct the inadequate care of FGM/C women and girls.
Keywords
Female
Genital Mutilation
Cutting
Share
Back to top